Autres langues Avedro, Inc.

Actions

AVDR

US05355N1090

Equipement, fournitures et distribution médicale

Temps Différé Nasdaq			Varia. 5j.	Varia. 1 janv.
- ^USD	-.--%		+0,61%	-

07/08/19	Avedro, Inc. annonce des résultats non audités pour le deuxième trimestre et le semestre clos le 30 juin 2019 ; révise les prévisions de chiffre d'affaires pour l'ensemble de l'exercice 2019.	CI
15/05/19	Transcript : Avedro, Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-14-2019 05:15 PM

Autres langues

09/09/20	INVESTIGATION ALERT: Nationally Ranked Litigation Firm Labaton Sucharow Announces Investigation of the Merger of Avedro, Inc. and Glaukos Corporation and Strongly Encourages Investors to Contact the Firm
08/09/20	INVESTIGATION ALERT: Nationally Ranked Litigation Firm Labaton Sucharow Announces Investigation of the Merger of Avedro, Inc. and Glaukos Corporation and Strongly Encourages Investors to Contact the Firm
22/11/19	Avedro, Inc.(NasdaqGM:AVDR) dropped from S&P TMI Index
21/11/19	Avedro, Inc. Announces Board Changes
21/11/19	AVEDRO INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
21/11/19	Avedro, Inc.(NasdaqGM:AVDR) dropped from NASDAQ Composite Index
21/11/19	Glaukos Corporation completed the acquisition of Avedro, Inc. from a group of sellers.
18/11/19	AVEDRO INC : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)
06/11/19	Avedro, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
06/11/19	Avedro, Inc. Announces Third Quarter 2019 Financial Results
09/10/19	Avedro Announces Schedule of Events at the American Academy of Ophthalmology Annual Meeting
11/09/19	Boost Epi-On™ Corneal Cross-Linking Data to Be Presented at the 37th Congress of the ESCRS
13/08/19	AVEDRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avedro, Inc. - AVDR
13/08/19	Certain Common Stock of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.
13/08/19	Certain Options of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.
13/08/19	Certain Warrants of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.
13/08/19	Certain Restricted Stock Units of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.
09/08/19	Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Avedro, Inc. (NASDAQ: AVDR) on Behalf of Avedro Shareholders and Encourages Avedro Investors to Contact the Firm
07/08/19	Avedro, Inc. Announces Resignation of Thomas W. Burns and Gilbert H. Kliman from the Board of Directors
07/08/19	Avedro, Inc. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2019; Revises Revenue Guidance for the Full Year of Fiscal 2019
07/08/19	Avedro, Inc. Announces Second Quarter 2019 Financial Results
07/08/19	Glaukos Corporation entered into a definitive merger agreement to acquire Avedro, Inc. from a group of sellers for approximately $490 million.
25/07/19	Avedro, Inc. to Report Second Quarter 2019 Financial Results on August 8, 2019
28/06/19	Avedro, Inc.(NasdaqGM:AVDR) added to Russell 2000 Dynamic Index
24/06/19	Avedro, Inc.(NasdaqGM:AVDR) added to S&P TMI Index